Global Enoxaparin Sodium For Injection 麻豆原创 Growth 2025-2031

Publication ID:

LPI02254121

Publication Date:

February 27, 2025

Pages:

117

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Enoxaparin Sodium For Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Enoxaparin Sodium For Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Enoxaparin Sodium For Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Enoxaparin Sodium For Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Enoxaparin Sodium For Injection players cover Sanofi, Teva Pharmaceutical, Techdow (Hepalink), Fresenius Kabi, Amphastar Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淓noxaparin Sodium For Injection Industry Forecast鈥� looks at past sales and reviews total world Enoxaparin Sodium For Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Enoxaparin Sodium For Injection sales for 2025 through 2031. With Enoxaparin Sodium For Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enoxaparin Sodium For Injection industry.
This Insight Report provides a comprehensive analysis of the global Enoxaparin Sodium For Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enoxaparin Sodium For Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Enoxaparin Sodium For Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enoxaparin Sodium For Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enoxaparin Sodium For Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Enoxaparin Sodium For Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
40mg
100mg
Other
Segmentation by Application:
Prevents Intravenous Thrombosis
Deep Vein Embolism Treatment
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi
Teva Pharmaceutical
Techdow (Hepalink)
Fresenius Kabi
Amphastar Pharmaceuticals
Hangzhou Jiuyuan Gene Engineering
Suzhou Erye Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Chengdu Baiyu Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Beijing SL Pharmaceutical
Troikaa Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Enoxaparin Sodium For Injection market?
What factors are driving Enoxaparin Sodium For Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enoxaparin Sodium For Injection market opportunities vary by end market size?
How does Enoxaparin Sodium For Injection break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Enoxaparin Sodium For Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Enoxaparin Sodium For Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Enoxaparin Sodium For Injection by Country/Region, 2020, 2024 & 2031
2.2 Enoxaparin Sodium For Injection Segment by Type
2.2.1 40mg
2.2.2 100mg
2.2.3 Other
2.3 Enoxaparin Sodium For Injection Sales by Type
2.3.1 Global Enoxaparin Sodium For Injection Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Enoxaparin Sodium For Injection Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Enoxaparin Sodium For Injection Sale Price by Type (2020-2025)
2.4 Enoxaparin Sodium For Injection Segment by Application
2.4.1 Prevents Intravenous Thrombosis
2.4.2 Deep Vein Embolism Treatment
2.4.3 Other
2.5 Enoxaparin Sodium For Injection Sales by Application
2.5.1 Global Enoxaparin Sodium For Injection Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Enoxaparin Sodium For Injection Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Enoxaparin Sodium For Injection Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Enoxaparin Sodium For Injection Breakdown Data by Company
3.1.1 Global Enoxaparin Sodium For Injection Annual Sales by Company (2020-2025)
3.1.2 Global Enoxaparin Sodium For Injection Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Enoxaparin Sodium For Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Enoxaparin Sodium For Injection Revenue by Company (2020-2025)
3.2.2 Global Enoxaparin Sodium For Injection Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Enoxaparin Sodium For Injection Sale Price by Company
3.4 Key Manufacturers Enoxaparin Sodium For Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enoxaparin Sodium For Injection Product Location Distribution
3.4.2 Players Enoxaparin Sodium For Injection Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Enoxaparin Sodium For Injection by Geographic Region
4.1 World Historic Enoxaparin Sodium For Injection 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Enoxaparin Sodium For Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Enoxaparin Sodium For Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Enoxaparin Sodium For Injection 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Enoxaparin Sodium For Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Enoxaparin Sodium For Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Enoxaparin Sodium For Injection Sales Growth
4.4 APAC Enoxaparin Sodium For Injection Sales Growth
4.5 Europe Enoxaparin Sodium For Injection Sales Growth
4.6 Middle East & Africa Enoxaparin Sodium For Injection Sales Growth
5 Americas
5.1 Americas Enoxaparin Sodium For Injection Sales by Country
5.1.1 Americas Enoxaparin Sodium For Injection Sales by Country (2020-2025)
5.1.2 Americas Enoxaparin Sodium For Injection Revenue by Country (2020-2025)
5.2 Americas Enoxaparin Sodium For Injection Sales by Type (2020-2025)
5.3 Americas Enoxaparin Sodium For Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enoxaparin Sodium For Injection Sales by Region
6.1.1 APAC Enoxaparin Sodium For Injection Sales by Region (2020-2025)
6.1.2 APAC Enoxaparin Sodium For Injection Revenue by Region (2020-2025)
6.2 APAC Enoxaparin Sodium For Injection Sales by Type (2020-2025)
6.3 APAC Enoxaparin Sodium For Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Enoxaparin Sodium For Injection by Country
7.1.1 Europe Enoxaparin Sodium For Injection Sales by Country (2020-2025)
7.1.2 Europe Enoxaparin Sodium For Injection Revenue by Country (2020-2025)
7.2 Europe Enoxaparin Sodium For Injection Sales by Type (2020-2025)
7.3 Europe Enoxaparin Sodium For Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Enoxaparin Sodium For Injection by Country
8.1.1 Middle East & Africa Enoxaparin Sodium For Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Enoxaparin Sodium For Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Enoxaparin Sodium For Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Enoxaparin Sodium For Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enoxaparin Sodium For Injection
10.3 Manufacturing Process Analysis of Enoxaparin Sodium For Injection
10.4 Industry Chain Structure of Enoxaparin Sodium For Injection
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enoxaparin Sodium For Injection Distributors
11.3 Enoxaparin Sodium For Injection Customer
12 World Forecast Review for Enoxaparin Sodium For Injection by Geographic Region
12.1 Global Enoxaparin Sodium For Injection 麻豆原创 Size Forecast by Region
12.1.1 Global Enoxaparin Sodium For Injection Forecast by Region (2026-2031)
12.1.2 Global Enoxaparin Sodium For Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Enoxaparin Sodium For Injection Forecast by Type (2026-2031)
12.7 Global Enoxaparin Sodium For Injection Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.1.3 Sanofi Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Teva Pharmaceutical
13.2.1 Teva Pharmaceutical Company Information
13.2.2 Teva Pharmaceutical Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.2.3 Teva Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Pharmaceutical Main Business Overview
13.2.5 Teva Pharmaceutical Latest Developments
13.3 Techdow (Hepalink)
13.3.1 Techdow (Hepalink) Company Information
13.3.2 Techdow (Hepalink) Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.3.3 Techdow (Hepalink) Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Techdow (Hepalink) Main Business Overview
13.3.5 Techdow (Hepalink) Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.4.3 Fresenius Kabi Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Amphastar Pharmaceuticals
13.5.1 Amphastar Pharmaceuticals Company Information
13.5.2 Amphastar Pharmaceuticals Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.5.3 Amphastar Pharmaceuticals Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Amphastar Pharmaceuticals Main Business Overview
13.5.5 Amphastar Pharmaceuticals Latest Developments
13.6 Hangzhou Jiuyuan Gene Engineering
13.6.1 Hangzhou Jiuyuan Gene Engineering Company Information
13.6.2 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.6.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hangzhou Jiuyuan Gene Engineering Main Business Overview
13.6.5 Hangzhou Jiuyuan Gene Engineering Latest Developments
13.7 Suzhou Erye Pharmaceutical
13.7.1 Suzhou Erye Pharmaceutical Company Information
13.7.2 Suzhou Erye Pharmaceutical Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.7.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Suzhou Erye Pharmaceutical Main Business Overview
13.7.5 Suzhou Erye Pharmaceutical Latest Developments
13.8 Nanjing King-friend Biochemical Pharmaceutical
13.8.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
13.8.2 Nanjing King-friend Biochemical Pharmaceutical Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.8.3 Nanjing King-friend Biochemical Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Nanjing King-friend Biochemical Pharmaceutical Main Business Overview
13.8.5 Nanjing King-friend Biochemical Pharmaceutical Latest Developments
13.9 Chengdu Baiyu Pharmaceutical
13.9.1 Chengdu Baiyu Pharmaceutical Company Information
13.9.2 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.9.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Chengdu Baiyu Pharmaceutical Main Business Overview
13.9.5 Chengdu Baiyu Pharmaceutical Latest Developments
13.10 Hebei Changshan Biochemical Pharmaceutical
13.10.1 Hebei Changshan Biochemical Pharmaceutical Company Information
13.10.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.10.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Hebei Changshan Biochemical Pharmaceutical Main Business Overview
13.10.5 Hebei Changshan Biochemical Pharmaceutical Latest Developments
13.11 Beijing SL Pharmaceutical
13.11.1 Beijing SL Pharmaceutical Company Information
13.11.2 Beijing SL Pharmaceutical Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.11.3 Beijing SL Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Beijing SL Pharmaceutical Main Business Overview
13.11.5 Beijing SL Pharmaceutical Latest Developments
13.12 Troikaa Pharmaceuticals
13.12.1 Troikaa Pharmaceuticals Company Information
13.12.2 Troikaa Pharmaceuticals Enoxaparin Sodium For Injection Product Portfolios and Specifications
13.12.3 Troikaa Pharmaceuticals Enoxaparin Sodium For Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Troikaa Pharmaceuticals Main Business Overview
13.12.5 Troikaa Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.